Strategic Wealth Partners was acquired by Kovitz Investment Group Partners, LLC ("Kovitz"), a registered investment adviser with the SEC on May 1, 2024. Strategic Wealth Partners is now a division of Kovitz and its registered investment adviser. Materials created prior to this date were created by Strategic Wealth Partners and are accurate as of the time of publishing.

Kathy Klein Award Announcement

We are proud to announce that SWP’s Wealth Advisor, Kathy Klein, received the Greater Milwaukee Foundation’s Herbert J. Mueller 2024 Outstanding Professional Adviser of the Year award! She was honored for her work empowering clients and communities through financial planning and charitable giving.

“Everyone I meet – whether a client or a prospect – is like a gift,” said Kathy. “We get the reward of seeing their dreams and aspirations for themselves and their kids come to fruition. It’s pretty spectacular.”

The Herbert J. Mueller Society is the Foundation’s way of saying thank you to advisers who have championed the Foundation to their networks and charitably minded clients.  She was honored at the Greater Milwaukee Foundation’s Herbert J. Mueller Society luncheon last week.

Read Kathy’s full write-up and more information on the Greater Milwaukee Foundation here: https://www.greatermilwaukeefoundation.org/news/post/kathy-klein

Investments
Investing Is Not Gambling
I have many pet peeves. I don’t like it when pillows in our house are lying on the floor. It irritates me when people talk on speaker phone in public. It drives me crazy when people rush to stand up in the aisle of an airplane once it lands (I’m really not as angry as it might seem).
Read More
Financial Planning
What’s New in Medicare for 2025
Every year, we encourage our clients enrolled in a Medicare Part D stand-alone prescription plan to take a few minutes to verify that their existing plan remains the best option for them. For the 2025 plan year, there’s a little more urgency, as some big changes are occurring that have never been a factor before. Starting in 2025, Medicare is setting a $2,000 cap on out-of-pocket drug costs for those with Part D drug plans.  From brokers I have spoken with, this has caused a lot of turmoil in this market as some providers are changing what drugs will be covered under their formularies, co-pays, deductibles, and coverage of brand versus generic.  If you were happy with your Part D drug plan in 2024, it could be a different story in 2025.
Read More